Mark Thronson, Partner, Dickstein Shapiro LLP to Speak at KC’s Patent Term Adjustment: 2015 Final Rules Live Webcast
New York, NY, May 06, 2015 --(PR.com)-- The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Mark Thronson, Partner, Dickstein Shapiro LLP will speak at the Knowledge Congress’ webcast entitled: “Patent Term Adjustment: 2015 Final Rules LIVE Webcast.” This event is scheduled for May 27, 2015 @ 3:00 PM to 5:00 PM (ET).
For further details, please visit:
http://theknowledgegroup.org/event_name/patent-term-adjustment-2015-final-rules-live-webcast/
About Mark Thronson
Mark Thronson is a partner in Dickstein Shapiro’s Intellectual Property Practice. Mark has thirty-two years of successful experience in virtually every aspect of patent law, including patent litigation, patent post-grant proceedings, patent prosecution, opinions/counseling, patent licensing, and alternative dispute resolution. Mark has represented many of the world’s largest and most important companies in a wide range of technologies.
From 1982 to 1988, Mark was an examiner at the U.S. Patent and Trademark Office. From 1994 to 2009, Mark was an adjunct professor at Johns Hopkins University, where he taught intellectual property law to graduate business students. In 2013, he received the prestigious Burton Award for distinguished legal writing. Mark has an undergraduate degree in civil engineering, and he received his law degree, with honors, from George Washington University.
About Dickstein Shapiro LLP
Market Leading Specialty FirmSM
Founded in 1953, Dickstein Shapiro is internationally recognized for its work with clients, from start-ups to Fortune 500 corporations. Dickstein Shapiro provides strategic counsel and develops multidisciplinary legal solutions by leveraging its core strengths—litigation, regulatory, transactions, and advocacy—to successfully advance clients’ business interests.
The firm’s intellectual property attorneys are located in Los Angeles, New York, Stamford, CT, and Washington, DC. The firm combines decades of intellectual property litigation experience, throughout the United States, and globally, with a robust prosecution, procurement, and asset management practice to devise strategies that help clients protect and maximize the value of their intellectual property assets.
Event Synopsis:
The United States Patent and Trademark Office (PTO) issued a final rule regarding the effect of filing a Request for Continued Examination (RCE) on Patent Term Adjustment (PTA). In the case of Novartis v. Lee, the Federal Circuit generally agreed to limit the PTA after the filing of an RCE. The Federal Circuit also held that the time from patent application allowance to issuance is not equivalent to the time spent in examination since that period ends when a Notice of Allowance (NOA) is issued. The patent statute nominally guarantees that a patent will issue within three years of filing. If the USPTO delays in issuing the patent, the patentee will be awarded PTA of a day for each day of delay by the USPTO.
Filers should be aware that, under final rule 37 CFR 1.704(c)(12) effective on March 10, 2015, filing an RCE after NOA is considered a failure to reasonably conclude prosecution, and reduces a PTA by the number of days from mailing of NOA to RCE filing (Rule 703). Rule 704 contains an exception to the above when the RCE is filed only to submit an Information Disclosure Statement (IDS). If it is stated that all information in the IDS was previously cited or issued by a foreign patent office less than 30 days prior to filing of the IDS, the RCE will not reduce available PTA.
In this 2-hour, live Webcast, a panel of key thought leaders organized by The Knowledge Group will review and discuss the nuances and changes in regulations regarding Patent Term Adjustment (PTA) and help attendees understand when to file a Request for Continued Examination (RCE) with the U.S. Patent and Trademark Office (USPTO). The speakers will discuss the consequences of the new ruling and provide best practices for optimal filing.
Key topics include:
Patent Term Adjustment (PTA)
Novartis AG v. Lee: Consequences
Revisions in the Rule
Request for Continued Examination (RCE)
Statute 35 U.S.C. 154(b)(1)(B) – Provisions
Potentiality to Create Precedent
B-term Delay
Recent Regulatory Updates
Non-Compliance Risks
About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
The Knowledge Congress was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register to an event, please visit: www.knowledgecongress.org
For further details, please visit:
http://theknowledgegroup.org/event_name/patent-term-adjustment-2015-final-rules-live-webcast/
About Mark Thronson
Mark Thronson is a partner in Dickstein Shapiro’s Intellectual Property Practice. Mark has thirty-two years of successful experience in virtually every aspect of patent law, including patent litigation, patent post-grant proceedings, patent prosecution, opinions/counseling, patent licensing, and alternative dispute resolution. Mark has represented many of the world’s largest and most important companies in a wide range of technologies.
From 1982 to 1988, Mark was an examiner at the U.S. Patent and Trademark Office. From 1994 to 2009, Mark was an adjunct professor at Johns Hopkins University, where he taught intellectual property law to graduate business students. In 2013, he received the prestigious Burton Award for distinguished legal writing. Mark has an undergraduate degree in civil engineering, and he received his law degree, with honors, from George Washington University.
About Dickstein Shapiro LLP
Market Leading Specialty FirmSM
Founded in 1953, Dickstein Shapiro is internationally recognized for its work with clients, from start-ups to Fortune 500 corporations. Dickstein Shapiro provides strategic counsel and develops multidisciplinary legal solutions by leveraging its core strengths—litigation, regulatory, transactions, and advocacy—to successfully advance clients’ business interests.
The firm’s intellectual property attorneys are located in Los Angeles, New York, Stamford, CT, and Washington, DC. The firm combines decades of intellectual property litigation experience, throughout the United States, and globally, with a robust prosecution, procurement, and asset management practice to devise strategies that help clients protect and maximize the value of their intellectual property assets.
Event Synopsis:
The United States Patent and Trademark Office (PTO) issued a final rule regarding the effect of filing a Request for Continued Examination (RCE) on Patent Term Adjustment (PTA). In the case of Novartis v. Lee, the Federal Circuit generally agreed to limit the PTA after the filing of an RCE. The Federal Circuit also held that the time from patent application allowance to issuance is not equivalent to the time spent in examination since that period ends when a Notice of Allowance (NOA) is issued. The patent statute nominally guarantees that a patent will issue within three years of filing. If the USPTO delays in issuing the patent, the patentee will be awarded PTA of a day for each day of delay by the USPTO.
Filers should be aware that, under final rule 37 CFR 1.704(c)(12) effective on March 10, 2015, filing an RCE after NOA is considered a failure to reasonably conclude prosecution, and reduces a PTA by the number of days from mailing of NOA to RCE filing (Rule 703). Rule 704 contains an exception to the above when the RCE is filed only to submit an Information Disclosure Statement (IDS). If it is stated that all information in the IDS was previously cited or issued by a foreign patent office less than 30 days prior to filing of the IDS, the RCE will not reduce available PTA.
In this 2-hour, live Webcast, a panel of key thought leaders organized by The Knowledge Group will review and discuss the nuances and changes in regulations regarding Patent Term Adjustment (PTA) and help attendees understand when to file a Request for Continued Examination (RCE) with the U.S. Patent and Trademark Office (USPTO). The speakers will discuss the consequences of the new ruling and provide best practices for optimal filing.
Key topics include:
Patent Term Adjustment (PTA)
Novartis AG v. Lee: Consequences
Revisions in the Rule
Request for Continued Examination (RCE)
Statute 35 U.S.C. 154(b)(1)(B) – Provisions
Potentiality to Create Precedent
B-term Delay
Recent Regulatory Updates
Non-Compliance Risks
About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
The Knowledge Congress was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register to an event, please visit: www.knowledgecongress.org
Contact
The Knowledge Congress
Thomas LaPointe, Jr., Executive Director
1.800.578.4370
www.knowledgecongress.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Thomas LaPointe, Jr., Executive Director
1.800.578.4370
www.knowledgecongress.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Contact
Categories